Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$809,435
+$304,400 QoQ
Shares Held
114,327
+81.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#44
of 164 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Sanctuary Advisors, LLC holds $679,497,428 across 14 Drug Manufacturers - General names. GRFS ranks #13 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
247,625 | $297,008,878 | |
| 2 | ABBV |
AbbVie Inc.
|
474,171 | $119,320,390 | |
| 3 | JNJ |
Johnson & Johnson
|
393,933 | $100,047,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
370,246 | $47,576,611 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
203,044 | $25,652,578 | |
| 6 | PFE |
Pfizer Inc
|
1,059,033 | $25,501,514 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
384,190 | $22,137,027 | |
| 8 | NVS |
Novartis AG
|
89,153 | $13,972,058 |
All Filings in GRFS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $809,435 | 114,327 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $505,035 | 62,972 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $455,877 | 48,757 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $416,666 | 41,834 | Shares | Sole | 2026-01-06 | |
| 2025-06-30 | $386,234 | 42,725 | Shares | Sole | 2026-01-06 | |
| 2025-03-31 | $297,439 | 41,834 | Shares | Sole | 2026-01-06 | |
| 2024-12-31 | $277,631 | 37,316 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $318,667 | 35,886 | Shares | Sole | 2024-11-25 | |
| No filing history on record for this holder in this stock. | ||||||